Efectos adversos de atazanavir / Adverse effects of atazanavir
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 26(supl.17): 41-44, dic. 2008. tab
Article
in Spanish
| IBECS
| ID: ibc-177839
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
Atazanavir es un fármaco que inhibe la proteasa del virus de la inmunodeficiencia humana (VIH) con muchas de las características de otros inhibidores de la proteasa y algunas ventajas sobre éstos, como la posología sólo una vez al día, la baja carga de comprimidos, la menor alteración gastrointestinal y un perfil metabólico más favorable, incluida la alteración del metabolismo de los hidratos de carbono. La hiperbilirrubinemia y la ictericia secundaria son su principal efecto adverso, aunque en raras ocasiones lleva a la suspensión del fármaco. Otros efectos adversos, como la nefrolitiasis o las alteraciones electrocardiográficas, son francamente raras
ABSTRACT
Atazanavir is a drug that inhibits HIV protease. It has many of the characteristics of other protease inhibitors and also some advantages over these, such as the single dose of once per day, low capsule load, less gastrointestinal problems and a very friendly metabolic profile, including carbohydrate metabolism. Secondary high plasma bilirubin and jaundice are its main adverse effect which only on rare occasions requires stopping the drug. Other adverse effects, such as nephrolithiasis or ECG changes are extremely rare
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Acquired Immunodeficiency Syndrome
/
HIV Protease Inhibitors
/
Antiretroviral Therapy, Highly Active
/
Atazanavir Sulfate
Limits:
Humans
Language:
Spanish
Journal:
Enferm. infecc. microbiol. clín. (Ed. impr.)
Year:
2008
Document type:
Article
Institution/Affiliation country:
Hospital Virgen de la Victoria/España